When people eat 600-800 calories daily because their GLP-1 medication kills their appetite entirely, they lose weight fast initially but hit a devastating plateau within weeks, followed by worsening side effects and declining body composition
Sustainability mandates are influencing material choices
But for many people, the changes don't stop at the number on the scale
" With Foundayo, we now have an oral option that delivered an average of 12.4% weight loss at the highest dose in clinical trials addressing both the clinical realities of obesity and the practical challenges patients face every day
The injectable requires subcutaneous injection, starting at a low dose of 0.25 mg weekly for the first four weeks and gradually increasing the dosage monthly
however, data from randomized double-blind placebo-controlled clinical trials lasting 34 months with a similar probiotic mixture ( Lactobacilli and Bifidobacteria ) suggest that a daily probiotic may improve clinical symptoms in MS (Tankou et al., 2018b)